Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-26-037240 General Corporate
Debt relative to revenue 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
132.63% · OPTIONAL · VALID
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.13% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.84% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-11.10% · CORE · VALID
Inventory pressure 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
59.25% · OPTIONAL · VALID
Gross margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
24.85% · CORE · VALID
Operating margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.19% · CORE · VALID
R&D intensity 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.53% · OPTIONAL · VALID
SBC intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.35% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 29.41%
Current 132.63%
Delta 103.22% Capex Intensity Increased
Previous 7.38%
Current 8.13%
Delta 0.75% Cash Generation Decreased
Previous 17.91%
Current 14.84%
Delta -3.07% Growth Decreased
Previous -7.04%
Current -11.10%
Delta -4.06% Inventory Pressure Increased
Previous 13.57%
Current 59.25%
Delta 45.67% Margin Decreased
Previous 25.32%
Current 24.85%
Delta -0.46% Profitability Decreased
Previous 16.73%
Current 15.19%
Delta -1.53% R And D Intensity Decreased
Previous 1.59%
Current 1.53%
Delta -0.06% Sbc Intensity Decreased
Previous 0.65%
Current 0.35%
Delta -0.29% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.